TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Cognitive Behavioural Group Therapy Versus Individual Supportive Therapy for the Prevention of Repeat Suicide Attempts: a Multicentre, Assessor-blinded, 2-parallel-group, Randomised, Superiority Trial
Brief Summary: The primary objective of this study is to evaluate the efficacy of a program of 6 sessions of Cognitive Behavioural Group Therapy (CBGT) (as compared to 6 sessions of Individual Supportive Therapy (IST)) designed for preventing repeat suicide attempts at 12 months post-psychotherapy in adults admitted to inpatient care for suicide attempts.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Lamotrigine | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Lamotrigine; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2
B: Arm Label: SAFE VET; Type: N/A; Interventions: Behavioral: SAFE VET | Arm Label: E-CARE; Type: N/A; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: SAFE VET; Assigned to Arm(s): SAFE VET
C: Arm Label: Individual supportive therapy; Type: ACTIVE_COMPARATOR; Interventions: Other: Baseline evaluation with a psychiatrist, Other: Individual supportive therapy, Other: Evaluations with a psychiatrist | Arm Label: Cognitive behavioural group therapy; Type: EXPERIMENTAL; Interventions: Other: Baseline evaluation with a psychiatrist, Other: Cognitive behavioural group therapy, Other: Evaluations with a psychiatrist | Intervention Type: OTHER; Name: Baseline evaluation with a psychiatrist; Assigned to Arm(s): Cognitive behavioural group therapy, Individual supportive therapy | Intervention Type: OTHER; Name: Individual supportive therapy; Assigned to Arm(s): Individual supportive therapy | Intervention Type: OTHER; Name: Cognitive behavioural group therapy; Assigned to Arm(s): Cognitive behavioural group therapy | Intervention Type: OTHER; Name: Evaluations with a psychiatrist; Assigned to Arm(s): Cognitive behavioural group therapy, Individual supportive therapy
D: Arm Label: Mentalization Based Treatment; Type: EXPERIMENTAL; Interventions: Behavioral: Mentalization Based Treatment | Arm Label: Treatment As Usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment As Usual | Intervention Type: BEHAVIORAL; Name: Mentalization Based Treatment; Assigned to Arm(s): Mentalization Based Treatment | Intervention Type: BEHAVIORAL; Name: Treatment As Usual; Assigned to Arm(s): Treatment As Usual

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Cognitive Behavioural Group Therapy Versus Individual Supportive Therapy for the Prevention of Repeat Suicide Attempts: a Multicentre, Assessor-blinded, 2-parallel-group, Randomised, Superiority Trial
Brief Summary: The primary objective of this study is to evaluate the efficacy of a program of 6 sessions of Cognitive Behavioural Group Therapy (CBGT) (as compared to 6 sessions of Individual Supportive Therapy (IST)) designed for preventing repeat suicide attempts at 12 months post-psychotherapy in adults admitted to inpatient care for suicide attempts.


Options:
A: Arm Label: therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive behavioural therapy | Arm Label: Standard treatment; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard treatment | Intervention Type: BEHAVIORAL; Name: Cognitive behavioural therapy; Assigned to Arm(s): therapy | Intervention Type: OTHER; Name: Standard treatment; Assigned to Arm(s): Standard treatment
B: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Active group; Type: EXPERIMENTAL; Interventions: Behavioral: Psychotherapy | Intervention Type: BEHAVIORAL; Name: Psychotherapy; Assigned to Arm(s): Active group
C: Arm Label: Individual supportive therapy; Type: ACTIVE_COMPARATOR; Interventions: Other: Baseline evaluation with a psychiatrist, Other: Individual supportive therapy, Other: Evaluations with a psychiatrist | Arm Label: Cognitive behavioural group therapy; Type: EXPERIMENTAL; Interventions: Other: Baseline evaluation with a psychiatrist, Other: Cognitive behavioural group therapy, Other: Evaluations with a psychiatrist | Intervention Type: OTHER; Name: Baseline evaluation with a psychiatrist; Assigned to Arm(s): Cognitive behavioural group therapy, Individual supportive therapy | Intervention Type: OTHER; Name: Individual supportive therapy; Assigned to Arm(s): Individual supportive therapy | Intervention Type: OTHER; Name: Cognitive behavioural group therapy; Assigned to Arm(s): Cognitive behavioural group therapy | Intervention Type: OTHER; Name: Evaluations with a psychiatrist; Assigned to Arm(s): Cognitive behavioural group therapy, Individual supportive therapy
D: Arm Label: CAMS treatment; Type: EXPERIMENTAL; Interventions: Behavioral: Psychotherapy | Arm Label: Treatment as usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Psychotherapy | Intervention Type: BEHAVIORAL; Name: Psychotherapy; Assigned to Arm(s): CAMS treatment, Treatment as usual

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Cognitive Behavioural Group Therapy Versus Individual Supportive Therapy for the Prevention of Repeat Suicide Attempts: a Multicentre, Assessor-blinded, 2-parallel-group, Randomised, Superiority Trial
Brief Summary: The primary objective of this study is to evaluate the efficacy of a program of 6 sessions of Cognitive Behavioural Group Therapy (CBGT) (as compared to 6 sessions of Individual Supportive Therapy (IST)) designed for preventing repeat suicide attempts at 12 months post-psychotherapy in adults admitted to inpatient care for suicide attempts.


Options:
A: Arm Label: Dialectical Behavior Therapy DBT; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: DBT | Arm Label: CAMS; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: CAMS | Intervention Type: BEHAVIORAL; Name: DBT; Assigned to Arm(s): Dialectical Behavior Therapy DBT | Intervention Type: BEHAVIORAL; Name: CAMS; Assigned to Arm(s): CAMS
B: Arm Label: Individual supportive therapy; Type: ACTIVE_COMPARATOR; Interventions: Other: Baseline evaluation with a psychiatrist, Other: Individual supportive therapy, Other: Evaluations with a psychiatrist | Arm Label: Cognitive behavioural group therapy; Type: EXPERIMENTAL; Interventions: Other: Baseline evaluation with a psychiatrist, Other: Cognitive behavioural group therapy, Other: Evaluations with a psychiatrist | Intervention Type: OTHER; Name: Baseline evaluation with a psychiatrist; Assigned to Arm(s): Cognitive behavioural group therapy, Individual supportive therapy | Intervention Type: OTHER; Name: Individual supportive therapy; Assigned to Arm(s): Individual supportive therapy | Intervention Type: OTHER; Name: Cognitive behavioural group therapy; Assigned to Arm(s): Cognitive behavioural group therapy | Intervention Type: OTHER; Name: Evaluations with a psychiatrist; Assigned to Arm(s): Cognitive behavioural group therapy, Individual supportive therapy
C: Arm Label: Internet-based ERITA-DK; Type: EXPERIMENTAL; Interventions: Behavioral: Internet-based Emotion Regulation Individual Therapy for Adolescents (ERITA-DK) | Arm Label: Treatment as Usual (TAU); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Internet-based Emotion Regulation Individual Therapy for Adolescents (ERITA-DK) | Intervention Type: BEHAVIORAL; Name: Internet-based Emotion Regulation Individual Therapy for Adolescents (ERITA-DK); Assigned to Arm(s): Internet-based ERITA-DK, Treatment as Usual (TAU)
D: Arm Label: ASAP Treatment and Brite; Type: EXPERIMENTAL; Interventions: Behavioral: As Safe As Possible, Behavioral: Brite | Arm Label: Treatment as Usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment as Usual | Intervention Type: BEHAVIORAL; Name: As Safe As Possible; Assigned to Arm(s): ASAP Treatment and Brite | Intervention Type: BEHAVIORAL; Name: Brite; Assigned to Arm(s): ASAP Treatment and Brite | Intervention Type: BEHAVIORAL; Name: Treatment as Usual; Assigned to Arm(s): Treatment as Usual

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Methocarbamol and Orphenadrine for Acute, Non-traumatic, Non-radicular Low Back Pain: A Randomized, Placebo Controlled, 3-armed Study
Brief Summary: Low back pain is a common cause of visit to emergency department. It is not clear if skeletal muscle relaxants are of benefit for patients with acute low back pain. This is a randomized study to determine if skeletal muscle relaxants, when combined with naproxen, improve outcomes more than naproxen alone


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Device: Heat Device | Arm Label: 2; Type: SHAM_COMPARATOR; Interventions: Device: Sham Device | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Drug: marketed analgesic | Arm Label: 4; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DEVICE; Name: Heat Device; Assigned to Arm(s): 1 | Intervention Type: DEVICE; Name: Sham Device; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: marketed analgesic; Assigned to Arm(s): 3 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 4
B: Arm Label: acupuncture; Type: EXPERIMENTAL; Interventions: Other: acupuncture, injection | Arm Label: injections of diclofenac; Type: ACTIVE_COMPARATOR; Interventions: Other: acupuncture, injection | Intervention Type: OTHER; Name: acupuncture, injection; Assigned to Arm(s): acupuncture, injections of diclofenac
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Naproxen, Drug: Placebo | Arm Label: Orphenadrine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Orphenadrine, Drug: Naproxen | Arm Label: Methocarbamol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methocarbamol, Drug: Naproxen | Intervention Type: DRUG; Name: Orphenadrine; Assigned to Arm(s): Orphenadrine | Intervention Type: DRUG; Name: Methocarbamol; Assigned to Arm(s): Methocarbamol | Intervention Type: DRUG; Name: Naproxen; Assigned to Arm(s): Methocarbamol, Orphenadrine, Placebo | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: ibuprofen + caffeine; Type: EXPERIMENTAL; Interventions: Drug: ibuprofen, Drug: caffeine | Arm Label: ibuprofen; Type: ACTIVE_COMPARATOR; Interventions: Drug: ibuprofen | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: ibuprofen; Assigned to Arm(s): ibuprofen, ibuprofen + caffeine | Intervention Type: DRUG; Name: caffeine; Assigned to Arm(s): ibuprofen + caffeine | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Internet-based Versus Face-to-face Clinical Care for Tinnitus: A Multi-study Randomised Control Trial
Brief Summary: The purpose of this study is to compare the effectiveness of a CBT-based internet intervention with face to face standard clinical care for adults with tinnitus in the United Kingdom.


Options:
A: Arm Label: TRT / EMDR; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: TRT / CBT | Arm Label: TRT / CBT; Type: ACTIVE_COMPARATOR; Interventions: Other: TRT / EMDR | Intervention Type: OTHER; Name: TRT / EMDR; Assigned to Arm(s): TRT / CBT | Intervention Type: BEHAVIORAL; Name: TRT / CBT; Assigned to Arm(s): TRT / EMDR
B: Arm Label: Group 1 : G_1; Type: ACTIVE_COMPARATOR; Interventions: Device: Acoustic CR-Stimulator ANM//Technology: Acoustic coordinated reset | Arm Label: Group 2 :G_2; Type: ACTIVE_COMPARATOR; Interventions: Device: Acoustic CR-Stimulator ANM//Technology: Acoustic coordinated reset | Arm Label: Group3 : G_3; Type: ACTIVE_COMPARATOR; Interventions: Device: Acoustic CR-Stimulator ANM//Technology: Acoustic coordinated reset | Arm Label: Group 4 : G_4; Type: ACTIVE_COMPARATOR; Interventions: Device: Acoustic CR-Stimulator ANM//Technology: Acoustic coordinated reset | Arm Label: Group5 : G_5; Type: PLACEBO_COMPARATOR; Interventions: Device: Acoustic CR-Stimulator ANM//Technology: Acoustic coordinated reset | Intervention Type: DEVICE; Name: Acoustic CR-Stimulator ANM//Technology: Acoustic coordinated reset; Assigned to Arm(s): Group 1 : G_1, Group 2 :G_2, Group 4 : G_4, Group3 : G_3, Group5 : G_5
C: Arm Label: Experimental group: iCBT; Type: EXPERIMENTAL; Interventions: Behavioral: CBT-based internet-intervention for tinnitus | Arm Label: Face-to-face clinical tinnitus care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Face-to-face clinical tinnitus care | Intervention Type: BEHAVIORAL; Name: CBT-based internet-intervention for tinnitus; Assigned to Arm(s): Experimental group: iCBT | Intervention Type: BEHAVIORAL; Name: Face-to-face clinical tinnitus care; Assigned to Arm(s): Face-to-face clinical tinnitus care
D: Arm Label: Specialized Care; Type: EXPERIMENTAL; Interventions: Behavioral: Specialized Care | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care | Intervention Type: BEHAVIORAL; Name: Specialized Care; Assigned to Arm(s): Specialized Care | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Usual Care

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison of Pre-oxygenation by Non-invasive Ventilation With High-flow Nasal Oxygen Therapy for Intubation of Intensive Care Patients in Cases of Acute Respiratory Failure: A Prospective, Randomized, Controlled Study (FLORALI 2)
Brief Summary: The aim of the study is to evaluate the incidence of severe hypoxemia episodes during the intubation procedure with two methods of pre-oxygenation:

1. NIV (Non Invasive Ventilation)
2. HFNC (High-flow nasal canula oxygen therapy)


Options:
A: Arm Label: NIV; Type: EXPERIMENTAL; Interventions: Procedure: Noninvasive ventilation | Arm Label: HFNC; Type: ACTIVE_COMPARATOR; Interventions: Procedure: High Flow nasal canula oxygen therapy | Intervention Type: PROCEDURE; Name: High Flow nasal canula oxygen therapy; Assigned to Arm(s): HFNC | Intervention Type: PROCEDURE; Name: Noninvasive ventilation; Assigned to Arm(s): NIV
B: Arm Label: HFNC (High Flow Nasal Cannulae); Type: EXPERIMENTAL; Interventions: Device: HFNC | Arm Label: CON (control); Type: ACTIVE_COMPARATOR; Interventions: Device: CON (control) | Intervention Type: DEVICE; Name: HFNC; Assigned to Arm(s): HFNC (High Flow Nasal Cannulae) | Intervention Type: DEVICE; Name: CON (control); Assigned to Arm(s): CON (control)
C: Arm Label: High Flow nasal cannula oxygen (HFNC); Type: EXPERIMENTAL; Interventions: Device: OPTIFLOW/ AIRVO | Arm Label: STANDARD high flow Face Mask (HFFM); Type: ACTIVE_COMPARATOR; Interventions: Procedure: STANDARD Face Mask | Intervention Type: DEVICE; Name: OPTIFLOW/ AIRVO; Assigned to Arm(s): High Flow nasal cannula oxygen (HFNC) | Intervention Type: PROCEDURE; Name: STANDARD Face Mask; Assigned to Arm(s): STANDARD high flow Face Mask (HFFM)
D: Arm Label: PREOXYFLOW; Type: EXPERIMENTAL; Interventions: Device: PREOXYFLOW | Arm Label: STANDARD FACE MASK; Type: ACTIVE_COMPARATOR; Interventions: Procedure: STANDARD FACE MASK | Intervention Type: DEVICE; Name: PREOXYFLOW; Assigned to Arm(s): PREOXYFLOW | Intervention Type: PROCEDURE; Name: STANDARD FACE MASK; Assigned to Arm(s): STANDARD FACE MASK

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Intra Uterine Extra Amniotic (200 μg ) Versus Vaginal (200 μg) Misoprostol for Second Trimester Pregnancy Termination: Randomized Controlled Trial
Brief Summary: The majority of second-trimester pregnancy termination performed in the United States are performed surgically by dilation and evacuation. The frequency of induction of abortion increases as gestational age advances. In the late second trimester and early third trimester, induction is the primary method of termination in cases of fetal abnormalities. In many other countries, however, induction is the primary method of abortion throughout the second trimester


Options:
A: Arm Label: Treatment; Type: EXPERIMENTAL; Interventions: Device: new crosslinked hyaluronan gel | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: new crosslinked hyaluronan gel; Assigned to Arm(s): Treatment
B: Arm Label: Misoprostol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol | Arm Label: Manual vacuum aspiration (MVA); Type: ACTIVE_COMPARATOR; Interventions: Procedure: surgery Manual vacuum aspiration (MVA) | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): Misoprostol | Intervention Type: PROCEDURE; Name: surgery Manual vacuum aspiration (MVA); Assigned to Arm(s): Manual vacuum aspiration (MVA)
C: Arm Label: Misoprostol 800 micrograms intravaginally; Type: EXPERIMENTAL; Interventions: Drug: misoprostol | Arm Label: expectant managment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: misoprostol; Assigned to Arm(s): Misoprostol 800 micrograms intravaginally
D: Arm Label: extra amniotic misoprostol; Type: EXPERIMENTAL; Interventions: Procedure: termination of second trimester pregnancy | Arm Label: vaginal misoprostol; Type: EXPERIMENTAL; Interventions: Procedure: termination of second trimester pregnancy | Intervention Type: PROCEDURE; Name: termination of second trimester pregnancy; Assigned to Arm(s): extra amniotic misoprostol, vaginal misoprostol

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Fresh to You: Multilevel Approaches in Low Income Housing to Increase F&V Intake
Brief Summary: Live Well, Viva Bien (LWVB) is an NCI-funded, cluster randomized controlled trial (RCT) that was conducted in 15 subsidized housing complexes to evaluate the efficacy of a multicomponent intervention comprised of a year-round, discount, mobile fresh F\&V market -'Fresh To You' (FTY)- that was paired with a nutrition education component including included educational newsletters, campaigns, taste-testings and videos in both English and Spanish. The primary aim of the LWVB grant was to study the efficacy of FTY combined with a motivational/educational intervention to see if it increased F\&V consumption compared to a Comparison intervention (attention placebo).


Options:
A: Arm Label: F&V Intervention; Type: EXPERIMENTAL; Interventions: Other: Environmental Intervention, Behavioral: Educational Intervention | Arm Label: Control Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Control | Intervention Type: OTHER; Name: Environmental Intervention; Assigned to Arm(s): F&V Intervention | Intervention Type: BEHAVIORAL; Name: Educational Intervention; Assigned to Arm(s): F&V Intervention | Intervention Type: BEHAVIORAL; Name: Control; Assigned to Arm(s): Control Intervention
B: Arm Label: 1- physical activity tailored; Type: EXPERIMENTAL; Interventions: Behavioral: physical activity tailored | Arm Label: 2 - physical activity standard; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: physical activity standard | Intervention Type: BEHAVIORAL; Name: physical activity tailored; Assigned to Arm(s): 1- physical activity tailored | Intervention Type: BEHAVIORAL; Name: physical activity standard; Assigned to Arm(s): 2 - physical activity standard
C: Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational text messaging | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Motivational text messaging; Assigned to Arm(s): Intervention Group
D: Arm Label: Lifestyle Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle Counseling | Arm Label: No Lifestyle Counseling; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Lifestyle Counseling; Assigned to Arm(s): Lifestyle Counseling

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Regional Citrate Versus Systemic Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Patients With Acute Kidney Injury
Brief Summary: The aim of this study is to evaluate the effect of regional citrate anticoagulation within the scope of continuous renal replacement (CRRT) in critically ill patients with acute kidney injury (AKI) on filter life span and 90-day all cause mortality.


Options:
A: Arm Label: heparin anticoagulation; Type: ACTIVE_COMPARATOR; Interventions: Drug: Heparin | Arm Label: citrate anticoagulation; Type: EXPERIMENTAL; Interventions: Drug: Citrate | Intervention Type: DRUG; Name: Heparin; Assigned to Arm(s): heparin anticoagulation | Intervention Type: DRUG; Name: Citrate; Assigned to Arm(s): citrate anticoagulation
B: Arm Label: Apixaban 2.5 mg twice daily and standard of care; Type: ACTIVE_COMPARATOR; Interventions: Drug: Apixaban 2.5 milligram Oral Tablet | Arm Label: Standard of care and no anticoagulation; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Apixaban 2.5 milligram Oral Tablet; Assigned to Arm(s): Apixaban 2.5 mg twice daily and standard of care
C: Arm Label: Tinzaparin; Type: EXPERIMENTAL; Interventions: Drug: Tinzaparin administration | Arm Label: Heparin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Heparin administration | Intervention Type: DRUG; Name: Tinzaparin administration; Assigned to Arm(s): Tinzaparin | Intervention Type: DRUG; Name: Heparin administration; Assigned to Arm(s): Heparin
D: Arm Label: saline flushes; Type: PLACEBO_COMPARATOR; Interventions: Drug: two stage regional citrate | Arm Label: one stage regional citrate; Type: ACTIVE_COMPARATOR; Interventions: Drug: one stage regional citrate | Arm Label: two stage regional citrate; Type: EXPERIMENTAL; Interventions: Drug: two stage regional citrate, Drug: one stage regional citrate | Intervention Type: DRUG; Name: two stage regional citrate; Assigned to Arm(s): saline flushes, two stage regional citrate | Intervention Type: DRUG; Name: one stage regional citrate; Assigned to Arm(s): one stage regional citrate, two stage regional citrate

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Regional Citrate Versus Systemic Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Patients With Acute Kidney Injury
Brief Summary: The aim of this study is to evaluate the effect of regional citrate anticoagulation within the scope of continuous renal replacement (CRRT) in critically ill patients with acute kidney injury (AKI) on filter life span and 90-day all cause mortality.


Options:
A: Arm Label: Heparin lock; Type: PLACEBO_COMPARATOR; Interventions: Drug: unfractionated heparin | Arm Label: Citrate lock; Type: EXPERIMENTAL; Interventions: Drug: Citrate 4% | Intervention Type: DRUG; Name: Citrate 4%; Assigned to Arm(s): Citrate lock | Intervention Type: DRUG; Name: unfractionated heparin; Assigned to Arm(s): Heparin lock
B: Arm Label: heparin anticoagulation; Type: ACTIVE_COMPARATOR; Interventions: Drug: Heparin | Arm Label: citrate anticoagulation; Type: EXPERIMENTAL; Interventions: Drug: Citrate | Intervention Type: DRUG; Name: Heparin; Assigned to Arm(s): heparin anticoagulation | Intervention Type: DRUG; Name: Citrate; Assigned to Arm(s): citrate anticoagulation
C: Arm Label: Tunneled dialysis catheter; Type: ACTIVE_COMPARATOR; Interventions: Device: Tunneled versus non-tunneled dialysis catheter insertion | Arm Label: Non-tunneled dialysis catheter; Type: ACTIVE_COMPARATOR; Interventions: Device: Tunneled versus non-tunneled dialysis catheter insertion | Intervention Type: DEVICE; Name: Tunneled versus non-tunneled dialysis catheter insertion; Assigned to Arm(s): Non-tunneled dialysis catheter, Tunneled dialysis catheter
D: Arm Label: citrate; Type: ACTIVE_COMPARATOR; Interventions: Drug: trisodium citrate | Arm Label: nadroparin; Type: ACTIVE_COMPARATOR; Interventions: Drug: nadroparin | Intervention Type: DRUG; Name: trisodium citrate; Assigned to Arm(s): citrate | Intervention Type: DRUG; Name: nadroparin; Assigned to Arm(s): nadroparin

Answer: B